The Three day International Pharma And Healthcare Exhibition-IPHEX 2024 to begin on August 28 Read more
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC) in the U.S. Read more
Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg Read more
Torque Pharma Honoured with MY FM Excellence Award for Most Trusted Corporate brand “Torque Pharma” in the pharmaceutical Category Read more
Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oral Solid Formulation Facility (F-I) at Panelav Read more
Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power Read more
Alembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg. Read more